This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Pityriasis rosea

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Pityriasis rosea is a common, acute, self limiting, papulosquamous condition thought to be due to HHV7 (1).

Many drugs have been linked with an extensive and often prolonged form of the disease e.g. - captopril, barbiturates, clonidine, gold (2).

Presentation is with fawn-coloured, large (around 2-10 cm in diameter), slightly raised, oval scaly patches which typically develop on the limbs and trunk - commonly known as an initial 'herald' lesion. Often there is a collarette of scale present at the margin in some lesions

Most commonly seen in children and young adults (2).

A systematic review concluded that "..When compared with placebo or no treatment, oral acyclovir probably leads to increased good or excellent, medical practitioner-rated rash improvement. However, evidence for the effect of acyclovir on itch was inconclusive. We found low- to moderate-quality evidence that erythromycin probably reduces itch more than placebo.." (3)

Click here for example images of pitryriasis rosea

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.